Not logged in Long term follow-up of patients undergoing prehabilitation prior to oesophagectomy: What happens to patients declining or withdrawing from prehabilitation exercise programmes? Knight, William; Moore, Jonathan; Whyte, Greg; Zylstra, Janine; Lane, Andy; Pate, James; Gervais-Andre, Louise; Maisey, Nick; Hill, Mark; Tham, Gemma; Lagergrens, Jesper; Kelly, Mark; Baker, Cara; Van Hemelrijck, Mieke; Goh, Vicky; Gossgae, James; Browning, Mike; Davies, Andrew Share Save
Genetic and immune landscape evolution in MMR-deficient colorectal cancer Challoner, Benjamin R.; Woolston, Andrew; Lau, David; Buzzetti, Marta; Fong, Caroline; Barber, Louise J.; Anandappa, Gayathri; Crux, Richard; Assiotis, Ioannis; Fenwick, Kerry; Begum, Ruwaida; Begum, Dipa; Lund, Tom; Sivamanoharan, Nanna; Sansano, Harold B.; Domingo-Arada, Melissa; Tran, Amina; Pandha, Hardev; Church, David; Eccles, Bryony; Ellis, Richard; Falk, Stephen; Hill, Mark; Krell, Daniel; Murugaesu, Nirupa; Nolan, Luke; Potter, Vanessa; Saunders, Mark; Shiu, Kai-Keen; Guettler, Sebastian; Alexander, James L.; Lazare-Iglesias, Hector; Kinross, James; Murphy, Jamie; von Loga, Katharina; Cunningham, David; Chau, Ian; Starling, Naureen; Ruiz-Banobre, Juan; Dhillon, Tony; Gerlinger, Marco Share Save
Prehabilitation exercise before oesophagectomy: long-term follow-up of patients declining/withdrawing from the program Knight, William; Moore, Jonathan L.; Whyte, Greg P.; Zylstra, Janine; Lane, Andrew M.; Pate, James; Gervais-Andre, Louise; Maisey, Nick; Hill, Mark; Tham, Gemma; Lagergren, Jesper; Kelly, Mark; Baker, Cara; Van Hemelrijck, Mieke; Goh, Vicky; Gossage, James; Browning, Mike; Davies, Andrew R. Share Save
Effect of peri-operative chemotherapy regimen on survival in the treatment of locally advanced oesophago- gastric adenocarcinoma- A comparison of the FLOT and 'MAGIC' regimens Moore, Jonathan L.; Kumar, Sacheen; Santaolalla, Aida; Patel, Pranav H.; Kapiris, Matthaios; Van Hemelrijck, Mieke; Maisey, Nick; Hill, Mark; Lagergren, Jesper; Gossage, James A.; Kelly, Mark; Chaudry, Asif; Allum, William H.; Baker, Cara R.; Cunningham, David; Davies, Andrew R.; Jacques, A.; Griffin, N.; Goh, V; Ngan, S.; Owczarczyk, K.; Lumsden, A.; Qureshi, A.; Deere, H.; Green, M.; Chang, F.; Mahadeva, U.; Gill-Barman, B.; George, S.; Ong, M.; Waters, J.; Cominos, M.; Sevitt, T.; Hynes, O.; Tham, G.; Bott, R. K.; Dunn, J. M.; Zeki, S. S. Share Save
Trifluridine/Tipiracil in Metastatic Colorectal Cancer: A UK Multicenter Real-world Analysis on Efficacy, Safety, Predictive and Prognostic Factors Stavraka, Chara; Pouptsis, Athanasios; Synowiec, Alicja; Angelis, Vasileios; Satterthwaite, Liyana; Khan, Sam; Chauhan, Meera; Holden, Chloe; Young, Sally; Karampera, Christina; Martinou, Maria; Mills-Baldock, Tina; Baxter, Mark; Barry, Ainsley; Eccles, Bryony; Iveson, Timothy; Shiu, Kai-Keen; Hill, Mark; Abdel-Raouf, Sherif; Graham, Janet Shirley; Thomas, Anne; Ross, Paul J. Share Save
Does adjuvant chemotherapy compared to surveillance improve recurrence free and overall survival in stage 3 rectal cancer patients? Adeleke, S. M.; George, S.; Galante, J. R.; Karova, M.; Dahal, L.; Choy, A.; Elwes, F.; Brown, N. F.; Summers, J.; Edwards, A. A.; Durve, M.; Mikropoulos, C.; Lees, K.; Hall, J.; Shah, R.; Hill, M.; Raman, R.; Clarke, A. Share Save
Share Save
A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: Results of the Panitumumab, Irinotecan & Ciclosporin in COLOrectal cancer therapy trial (PICCOLO) Middleton, Gary; Brown, Sarah; Lowe, Catherine; Maughan, Timothy; Gwyther, Stephen; Oliver, Alfred; Richman, Susan; Blake, Denise; Napp, Vicky; Marshall, Helen; Wadsley, Jonathan; Maisey, Nick; Chau, Ian; Hill, Mark; Gollins, Simon; Myint, Sun; Slater, Sarah; Wagstaff, John; Bridgewater, John; Seymour, Matthew Share Save
A randomised study evaluating the use of pyridoxine to avoid capecitabine dose modifications Corrie, P. G.; Bulusu, R.; Wilson, C. B.; Armstrong, G.; Bond, S.; Hardy, R.; Lao-Sirieix, S.; Parashar, D.; Ahmad, A.; Daniel, F.; Hill, M.; Wilson, G.; Blesing, C.; Moody, A. M.; McAdam, K.; Osborne, M. Share Save
Panitumumab in Combination With Irinotecan for Chemoresistant Advanced Colorectal Cancer: Results of PICCOLO, a Large Randomised Trial With Prospective Molecular Stratification Seymour, M. T.; Brown, S. R.; Richman, S.; Middleton, G. W.; Maughan, T. S.; Maisey, N.; Hill, M.; Olivier, C.; Napp, V.; Quirke, P. Share Save
Share Save
Share Save
Longitudinal quality of life and quality adjusted survival in a randomised controlled trial comparing six months of bolus fluorouracil/leucovorin vs. twelve weeks of protracted venous infusion fluorouracil as adjuvant chemotherapy for colorectal cancer Chau, I; Norman, AR; Cunningham, D; Iveson, T; Hill, M; Hickish, T; Lofts, F; Jodrell, D; Webb, A; Tait, D; Ross, PJ; Shellito, P; Oates, JR Share Save
Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF Sumpter, K; Harper-Wynne, C; Cunningham, D; Rao, S; Tebbutt, N; Norman, AR; Ward, C; Iveson, T; Nicolson, M; Hickish, T; Hill, M; Oates, J Share Save
Gemcitabine, cisplatin and methylprednisolone (GEM-P) is an effective salvage regimen in patients with relapsed and refractory lymphoma Ng, M; Waters, J; Cunningham, D; Chau, I; Horwich, A; Hill, M; Norman, AR; Wotherspoon, A; Catovsky, D Share Save
A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancer Chau, I; Norman, AR; Cunningham, D; Tait, D; Ross, PJ; Iveson, T; Hill, M; Hickish, T; Lofts, F; Jodrell, D; Webb, A; Oates, JR Share Save
Elderly patients with fluoropyrimidine and thymidylate synthase inhibitor-resistant advanced colorectal cancer derive similar benefit without excessive toxicity when treated with irinotecan monotherapy Chau, I; Norman, AR; Cunningham, D; Waters, JS; Topham, C; Middleton, G; Hill, M; Ross, PJ; Katopodis, R; Stewart, G; Oates, JR Share Save
A phase I/II study of oral uracil/tegafur (UFT), leucovorin and irinotecan in patients with advanced colorectal cancer Mackay, HJ; Hill, M; Twelves, C; Glasspool, R; Price, T; Campbell, S; Massey, A; Macham, MA; Uzzel, M; Bailey, SM; Martin, C; Cunningham, D Share Save
Share Save
Twelve weeks of protracted venous infusion of fluorouracil (5-FU) is as effective as 6 months of bolus 5-FU and folinic acid as adjuvant treatment in colorectal cancer Saini, A; Norman, AR; Cunningham, D; Chau, I; Hill, M; Tait, D; Hickish, T; Iveson, T; Lofts, F; Jodrell, D; Ross, PJ; Oates, J Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
